Landscape of drug-resistance mutations in kinase regulatory hotspots.

Briefings in Bioinformatics
Pora KimZhongming Zhao

Abstract

More than 48 kinase inhibitors (KIs) have been approved by Food and Drug Administration. However, drug-resistance (DR) eventually occurs, and secondary mutations have been found in the previously targeted primary-mutated cancer cells. Cancer and drug research communities recognize the importance of the kinase domain (KD) mutations for kinasopathies. So far, a systematic investigation of kinase mutations on DR hotspots has not been done yet. In this study, we systematically investigated four types of representative mutation hotspots (gatekeeper, G-loop, αC-helix and A-loop) associated with DR in 538 human protein kinases using large-scale cancer data sets (TCGA, ICGC, COSMIC and GDSC). Our results revealed 358 kinases harboring 3318 mutations that covered 702 drug resistance hotspot residues. Among them, 197 kinases had multiple genetic variants on each residue. We further computationally assessed and validated the epidermal growth factor receptor mutations on protein structure and drug-binding efficacy. This is the first study to provide a landscape view of DR-associated mutation hotspots in kinase's secondary structures, and its knowledge will help the development of effective next-generation KIs for better precision medicine.

References

Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Dec 10, 2002·Science·G ManningS Sudarsanam
Jul 31, 2003·Mutation Research·Igor B Rogozin, Youri I Pavlov
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
May 18, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eunice L KwakDaniel A Haber
Jun 10, 2005·Journal of Medicinal Chemistry·Bernd KuhnMartin Stahl
Feb 7, 2006·Journal of Molecular Graphics & Modelling·Junmei WangDavid A Case
Oct 13, 2006·Journal of Computational Chemistry·Christopher S Page, Paul A Bates
Nov 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marissa N BalakWilliam Pao
Jan 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cai-Hong YunMichael J Eck
Sep 11, 2008·Journal of Computer-aided Molecular Design·Jacob Kongsted, Ulf Ryde
Nov 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James BeanWilliam Pao
Dec 17, 2008·The Journal of Molecular Diagnostics : JMD·Wanlong MaMaher Albitar
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ketan S GajiwalaGeorge D Demetri
Apr 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yanan KuangPasi A Jänne
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tianhua GuoCristina R Antonescu
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michele BaccaraniUNKNOWN European LeukemiaNet
Dec 23, 2009·Nature Reviews. Molecular Cell Biology·Laura R PearceDario R Alessi
Oct 23, 2010·Nature Reviews. Cancer·William Pao, Juliann Chmielecki
Oct 29, 2010·The New England Journal of Medicine·Young Lim ChoiUNKNOWN ALK Lung Cancer Study Group
Jan 18, 2011·Expert Opinion on Investigational Drugs·Rina Barouch-Bentov, Karsten Sauer
Mar 25, 2011·Science Translational Medicine·Lecia V SequistJeffrey A Engelman
Apr 8, 2011·Combinatorial Chemistry & High Throughput Screening·Junmei Wang, Tingjun Hou
May 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jenn-Yu WuPan-Chyr Yang
Oct 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wendy T ParkerSusan Branford
Nov 3, 2011·PloS One·Rama Krishna KanchaJustus Duyster
Jan 19, 2012·British Journal of Pharmacology·Joost C M UitdehaagGuido J R Zaman
Apr 14, 2012·Journal of Chemical Information and Modeling·Junmei Wang, Tingjun Hou

❮ Previous
Next ❯

Citations

Nov 3, 2020·Nucleic Acids Research·Ruifeng HuZhongming Zhao
Nov 25, 2020·International Journal of Molecular Sciences·Bala M XavierJyh-Yeuan Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.